Cargando…
Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury
Atherosclerosis is the leading cause of death and disability around the world, with current treatments limited by neointimal hyperplasia. Our goal was to synthesize, characterize, and evaluate an injectable, targeted nanomaterial that will specifically bind to the site of arterial injury. Our target...
Autores principales: | Kassam, Hussein A., Gillis, David C., Dandurand, Brooke R., Karver, Mark R., Tsihlis, Nick D., Stupp, Samuel I., Kibbe, Melina R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152859/ https://www.ncbi.nlm.nih.gov/pubmed/32121105 http://dx.doi.org/10.3390/nano10030420 |
Ejemplares similares
-
Pharmacokinetics and biodistribution of a collagen‐targeted peptide amphiphile for cardiovascular applications
por: Kassam, Hussein A., et al.
Publicado: (2020) -
Emerging therapies for smoke inhalation injury: a review
por: Mercel, Alexandra, et al.
Publicado: (2020) -
EMERGING ANTENATAL THERAPIES FOR CONGENITAL DIAPHRAGMATIC HERNIA-INDUCED PULMONARY HYPERTENSION IN PRECLINICAL MODELS
por: Marulanda, Kathleen, et al.
Publicado: (2020) -
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
por: Finneran, Dylan J., et al.
Publicado: (2019) -
Leptin and fractalkine: novel subcutaneous cytokines in burn injury
por: Friston, Dominic, et al.
Publicado: (2020)